| Financial Year |
March 31 2023 |
| Monetary Funds |
239,016,642.03 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
109,953,379.73 |
| Accounts Receivable |
627,168,194.04 |
| Advances to Suppliers |
9,550,675.06 |
| Other Receivables |
2,203,817.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
672,057,502.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
21,150,210.53 |
| Other Current Assets |
8,004,656.50 |
| Total Current Assets |
1,791,928,748.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
8,625,000.00 |
| Long-term Equity Investment |
-- |
| Investment Properties |
35,797,268.51 |
| Fixed Assetes |
1,709,117,098.48 |
| Under-construction Projects |
17,171,712.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
106,828,058.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,807,119.74 |
| Deferred Income Tax Assets |
35,863,663.13 |
| Other Non-Current Assets |
5,518,128.32 |
| Sub-Total of Non-Current Assets |
1,924,728,048.76 |
| Total Assets |
3,716,656,796.99 |
| Short-Term Loans |
532,532,452.39 |
| Trading Financial liabilities |
138,486.31 |
| Notes Payable |
238,224,976.98 |
| Accounts Payable |
483,953,386.27 |
| Accounts Received In Advance |
172,106.45 |
| Employee Compensation Payable |
23,919,872.90 |
| Taxes Payable |
4,769,552.85 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,373,984.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
695,328,021.69 |
| Other Current Liabilities |
24,132,863.47 |
| Sub-Total of Current Liabilities |
2,005,638,034.87 |
| Long-term Loans |
198,214,374.32 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
41,714,498.55 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
20,527,655.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
414,040,952.88 |
| Total Liabilities |
2,419,678,987.75 |
| Paid-In Capital(Or Share Stock) |
133,400,000.00 |
| Capital Surplus |
715,185,034.94 |
| Surplus Reserve |
57,763,754.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
378,705,411.81 |
| Minority Stockholder's Interest |
4,513,096.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,292,464,713.16 |
| Owner's Equity（Stockholder's Equity） |
1,296,977,809.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,716,656,796.99 |
